
Ifytrox TBM 500mg/62.5mg Injection
Marketer
Syntonic Lifesciences
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Ifytrox TBM 500mg/62.5mg Injection
Combiflox, a 500mg/62.5mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication solely under medical guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving, avoid operating vehicles if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Monitoring may involve laboratory tests to assess the medication's impact.
Uses of Ifytrox TBM 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Ifytrox TBM 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ifytrox TBM 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ifytrox TBM 500mg/62.5mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ifytrox TBM 500mg/62.5mg Injection works:
Ifytrox TBM Injection (500mg/62.5mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ifytrox TBM 500mg/62.5mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ifytrox TBM 500mg/62.5mg is generally deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impact on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Ifytrox TBM 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Ifytrox TBM 500mg/62.5mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ifytrox TBM 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Ifytrox TBM 500mg/62.5mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alterations for Ifytrox TBM 500mg/62.5mg Injection are unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Ifytrox TBM 500mg/62.5mg Injection :
Should you inadvertently skip a dose of Ifytrox TBM 500mg/62.5mg Injection, seek medical advice.
Facts to Know About Ifytrox TBM 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
